Rory Riggs
Founder
Description:
Rory Riggs is the Managing Member of Balfour, LLC a firm specializing in early-stage entrepreneurial activities in healthcare and biotechnology. He is also Chairman of Royalty Pharma AG. He recently served as the president and director of Biomatrix Corporation (NYSE Ticker: BXM) until it was sold to Genzyme Corporation in December, 2000. Mr. Riggs launched Biomatrix’s lead product, Synvisc, which is currently the third largest product for the treatment of osteoarthritis sold in the US. Prior to joining Biomatrix, Mr. Riggs was a director, president and CEO of the RF&P Corporation from 1991 to 1995. RF&P was sold in 1995 to the real estate arm of Lazard Freres. Prior to that Mr. Riggs was a managing director in Mergers and Acquisitions at Paine Webber and an associate with Strategic Planning Associates, the predecessor company to Mercer Management Consulting. Mr. Riggs has been involved in the start-up of many companies including: Genenews Limited, Cibus Genetics, Fibrogen, Inc., Royalty Pharma AG, Selectide Inc., Sugen Inc., eAppeals, LLC, Medrium, Inc., Pharmaceutical Partners, LLC and Pacific Media. Mr. Riggs received a BA from Middlebury College and MBA from Columbia University.
Summary:
Rory Riggs is the Managing Member of Balfour, LLC a firm specializing in early-stage entrepreneurial activities in healthcare and biotechnol...
Number of Registered Investments:2
Contact Details:
- Address: New York, New York, United States
- No email is provided
Location:New York, New York, United States
Email is Not Provided
Phone Number:New York, New York, United States
Updated August 2023. This content was crafted by an associate of Najafi Capital (“Najafi”) and is presented strictly for informational objectives. The details on this page neither advocate for nor dissuade the subscription, acquisition, or sale of any security or offering. The material Najafi evaluates for project owner screening and due diligence stems directly from the project owner presenting the investment opportunity. While Najafi perceives the information to have been sourced from trustworthy channels, there is no absolute assurance, warranty, or representation concerning its authenticity. Najafi renounces any liability regarding content provided by the project owner, inclusive of the data utilized to fulfill elements outlined on this page. Najafi is not accountable for the precision, legality, or the affirmation of subsequent details shared by the project owner.
Prospective investors are urged to perform their individual due diligence and authenticate the provided data. Investing inherently encompasses risks, inclusive of the potential loss of capital invested. All investors are recommended to ponder over these aspects in tandem with a chosen professional consultant to ascertain the suitability of an investment.
English 
Polish 